文献速递肿瘤 PET/CT

基于PET/CT的深度学习分级标签优化临床I期浸润性肺腺癌手术决策及其预测的生物学基础:一项多中心研究

PET/CT-based deep learning grading signature to optimize surgical decisions for clinical stage I invasive lung adenocarcinoma and biologic basis under its prediction: a multicenter study.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2023-09-19

该多中心回顾性研究基于2638例临床I期浸润性肺腺癌患者构建并验证了PET/CT深度学习分级标签(DLGS),用于预测组织学3级。DLGS在验证集、外部队列和前瞻性队列的AUC分别为0.862、0.844和0.851,均优于PET、CT和临床模型。在DLGS定义的高风险人群中,肺叶切除术较亚肺叶切除术改善预后(OS p=0.085,RFS p=0.038),系统淋巴结清扫优于局限淋巴结清扫(OS p=0.001,RFS p=0.041)。

要点

  • DLGS预测3级的AUC在验证集、外部队列和前瞻性队列分别为0.862、0.844和0.851,均优于PET、CT和临床模型。
  • DLGS定义的高风险人群中,肺叶切除术较亚肺叶切除术OS的p=0.085、RFS的p=0.038。
  • DLGS定义的高风险人群中,系统淋巴结清扫较局限淋巴结清扫OS的p=0.001、RFS的p=0.041。

核心结论

  • DLGS有潜力预测临床I期浸润性肺腺癌的组织学分级并实现手术治疗的个体化。
  • 其对其他地区的适用性需通过更大规模的国际研究进一步验证。

研究设计与样本

  • 回顾性纳入来自4个医疗中心的2638例临床I期浸润性肺腺癌患者,用于构建和验证DLGS。
  • 通过受试者工作特征曲线下面积(AUC)评估DLGS的预测性能。
  • 通过DLGS定义的风险组间生存分析探讨其优化手术治疗的潜力。
  • 通过比较风险组间的组织学模式、基因型改变、遗传通路和微环境免疫细胞浸润探索其生物学基础。

主要发现

  • DLGS预测3级在验证集(n=497)的AUC为0.862,外部队列(n=382)为0.844,前瞻性队列(n=600)为0.851。
  • DLGS的AUC显著优于PET模型(验证集0.814、外部队列0.810、前瞻性队列0.806)、CT模型(0.813、0.795、0.824)和临床模型(0.762、0.734、0.751)。
  • 在DLGS定义的高风险人群中,肺叶切除术较亚肺叶切除术预后更优,OS的p=0.085,RFS的p=0.038。
  • 在DLGS定义的高风险人群中,系统淋巴结清扫较局限淋巴结清扫预后更优,OS的p=0.001,RFS的p=0.041。

临床怎么用

  • 作者认为DLGS有潜力预测临床I期浸润性肺腺癌的组织学分级并实现手术治疗的个体化。
  • 原文未据此给出具体的临床推荐。

局限性

  • 其对其他地区的适用性需通过更大规模的国际研究进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: No consensus on a grading system for invasive lung adenocarcinoma had been built over a long period of time. Until October 2020, a novel grading system was proposed to quantify the whole landscape of histologic subtypes and proportions of pulmonary adenocarcinomas. This study aims to develop a deep learning grading signature (DLGS) based on positron emission tomography/computed tomography (PET/CT) to personalize surgical treatments for clinical stage I invasive lung adenocarcinoma and explore the biologic basis under its prediction. METHODS: A total of 2638 patients with clinical stage I invasive lung adenocarcinoma from 4 medical centers were retrospectively included to construct and validate the DLGS. The predictive performance of the DLGS was evaluated by the area under the receiver operating characteristic curve (AUC), its potential to optimize surgical treatments was investigated via survival analyses in risk groups defined by the DLGS, and its biological basis was explored by comparing histologic patterns, genotypic alternations, genetic pathways, and infiltration of immune cells in microenvironments between risk groups. RESULTS: The DLGS to predict grade 3 achieved AUCs of 0.862, 0.844, and 0.851 in the validation set (n = 497), external cohort (n = 382), and prospective cohort (n = 600), respectively, which were significantly better than 0.814, 0.810, and 0.806 of the PET model, 0.813, 0.795, and 0.824 of the CT model, and 0.762, 0.734, and 0.751 of the clinical model. Additionally, for DLGS-defined high-risk population, lobectomy yielded an improved prognosis compared to sublobectomy p = 0.085 for overall survival [OS] and p = 0.038 for recurrence-free survival [RFS]) and systematic nodal dissection conferred a superior prognosis to limited nodal dissection (p = 0.001 for OS and p = 0.041 for RFS). CONCLUSION: The DLGS harbors the potential to predict the histologic grade and personalize the surgical treatments for clinical stage I invasive lung adenocarcinoma. Its applicability to other territories should be further validated by a larger international study.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Zhong Y, Cai C, Chen T, et al. PET/CT-based deep learning grading signature to optimize surgical decisions for clinical stage I invasive lung adenocarcinoma and biologic basis under its prediction: a multicenter study. Eur J Nucl Med Mol Imaging. 2023. PMID: 37725128. doi:10.1007/s00259-023-06434-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。